Glenmark Pharmaceuticals (GLENMARK.NSE) null Earnings

31MarConfirmed
Jun 17
Sep 17
Dec 17
Mar 18
3.31
6.14
8.98
11.81

Details

Expected EPS
7.01
Actual EPS
5.37
Surprise EPS
-1.64
Surprise Percent
+23.4%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 5.37 per share for .

0 Comments

Share your thoughts